| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Belanoff Joseph K is a Chief Executive Officer at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $28.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | CORT Corcept Therapeutics Inc | Chief Executive Officer | Sell | 2,924 | $60.91 | $178,097.92 | - | +21.3% | -40.3% | |
| Jul 7, 2022 | CORT Corcept Therapeutics Inc | Chief Executive Officer | Sale+OE | 335,019 | $26.26 | $8,798,952.36 | -6.3% | -2.7% | -18.2% | |
| Dec 12, 2018 | CORT Corcept Therapeutics Inc | Chief Executive Officer | Sale+OE | 217,115 | $19.01 | $4,126,509.40 | -9.1% | - | - | |
| Nov 11, 2016 | CORT Corcept Therapeutics Inc | Chief Executive Officer | Sale+OE | 500,000 | $8.98 | $4,490,750.00 | -10.4% | - | - | |
| Nov 7, 2016 | CORT Corcept Therapeutics Inc | Chief Executive Officer | Sale+OE | 500,000 | $8.31 | $4,152,547.39 | -10.4% | - | - |